A study of cognitive impairment induced by chemotheraphy in breast cancer patients
10.3760/cma.j.issn.1674-6554.2013.04.007
- VernacularTitle:乳腺癌患者化疗后认知功能损害的研究
- Author:
Xingui CHEN
;
Jingjing LI
;
Chunyan ZHU
;
Fengqiong YU
;
Linlin QIU
;
Jingjie ZHANG
;
Kai WANG
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Chemotherapy;
Cognitive impairment;
Neuropsychological tests
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2013;(4):308-310
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the neuropsychological features of cognitive impairment induced by chemotherapy for breast cancer patients.Methods A neuropsychology battery was applied in this study.Seventy six breast cancer patients were enrolled in the test and classified as chemotherapy treatment patients(CT,n =38),and non-chemotherapy treatment patients(non-CT,n =38).Forty normal female people were also evaluated as healthy control(HC).Results Compared with HC and non-CT groups,the correct number of backward(CT:4.42±1.11,non-CT:5.18 ± 1.16,HC:5.13 ± 1.22),delayed recall (CT:8.55 ± 1.75,non-CT:9.58 ± 1.50,HC:10.13 ± 1.92) and recognition (CT:7.68 ± 1.90,non-CT:8.97 ± 1.62,HC:9.08 ± 2.09) were low in the CT group (P ＜ 0.01).The reaction time of Stroop test B (CT:(21.54 ± 5.02) s,non-CT:(19.37 ± 4.26) s,HC:(18.82 ± 3.05) s),Stroop test C (CT:(34.85 ± 8.46) s,non-CT:(31.02 ± 7.38) s,HC:(30.61 ± 7.83) s) and TMT test B(CT:(102.79± 11.90)s,non-CT:(96.22 ± 12.07) s,HC:(97.21 ± 11.64)s) were long in the CT group (P ＜ 0.05).There were no significant differences in the Forward,Immediate Recall,Stroop test A,TMT test A and VFT among three groups(P＞ 0.05).Conclusion Breast cancer patients with chemotherapy treatment have cognitive impairment in the domains of memory,attention and executive functions.
